Pulling SEC filings + quote and writing the call…
Pulling SEC filings + quote and writing the call…
CLOVER HEALTH INVESTMENTS, CORP. /DE
Last earnings +2.7% on 2026-05-06
Revenue grew 40.3% YoY; but unprofitable (net margin -4.4%).
Rules-based read computed from SEC figures — no Anthropic key set. Add ANTHROPIC_API_KEY to .env.local for a full Claude analysis.
CLOVER HEALTH INVESTMENTS, CORP. /DE shows $1.92B in FY2025 revenue (+40.3% YoY), a -4.4% net margin, and -27.7% ROE.
The risks, catalysts, 12-month price target and the cited SEC figures behind this rating — with Pro.
Unlock with Pro$19/mo · cancel anytime
Sources: SEC EDGAR (CIK 0001801170, latest 10-Q filed 2026-05-08) · EODHD · rules-based read · as of 6/18/2026, 5:38:40 AM.
Research and education only — not financial advice. Calls are generated from SEC filings and a delayed/third-party price feed, may be wrong or out of date, and are not a recommendation to buy or sell any security. Do your own research.
| Line item | FY21 | FY22 | FY23 | FY24 | FY25 |
|---|---|---|---|---|---|
| Revenue | $1.47B | $1.10B | $1.26B | $1.37B | $1.92B |
| Gross profit | -$79.2M | $22.7M | $257M | — | — |
| Operating income | -$637M | -$287M | -$205M | -$45.7M | -$85.5M |
| Net income | -$588M | -$340M | -$213M | -$43.0M | -$85.5M |
| Diluted EPS | -$1.42 | -$0.71 | -$0.44 | — | — |
| Net margin | -39.9% | -31.0% | -16.9% | -3.1% | -4.4% |
Annual figures from SEC 10-K XBRL filings. Open the filing links below for full statement detail.
Computed from SEC XBRL annual figures + the current quote. EV and ROIC use long-term + current debt where filed; estimates, not investment advice.
501 tracked peers · median
Source: EODHD. Yield = trailing-12-month dividends ÷ price.
Last 90 days: 0 open-market buys · 7 sales
| 2026-06-16 | OLDAKOWSKI JOSEPH FRANK VP OF FINANCE AND CONTROLLER | Sell | 12.1K @ $4.86 | $58.8K |
| 2026-06-15 | Soares Karen Chief Legal Officer | Sell | 4.68K @ $4.61 | $21.6K |
| 2026-06-15 | Reynoso Jamie L. CEO, Medicare Advantage | Sell | 6.35K @ $4.61 | $29.3K |
| 2026-06-11 | Reynoso Jamie L. CEO, Medicare Advantage | Sell | 7.29K @ $4.91 | $35.8K |
| 2026-05-28 | Wai Conrad CEO, Counterpart Health | Sell | 220K @ $3.99 | $879K |
| 2026-05-18 | Edwards Carladenise Armbrister Director | Sell | 67.2K @ $3.42 | $230K |
| 2026-05-16 | THORNTON JOSEPH CLAY Interim CFO | Tax | 16.9K @ $3.47 | $58.8K |
| 2026-05-13 | Priest Brady Patrick CEO of Clover Care Services | Sell | 98.0K @ $3.52 | $345K |